SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
Provided By PR Newswire
Last update: Sep 13, 2023
NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Read more at prnewswire.com33.64
-0.22 (-0.65%)
Find more stocks in the Stock Screener
TGTX Latest News and Analysis
8 days ago - ChartmillApplying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
